Delivery Order SPE2DB24D1201-SPE2DB25FJEGC
- Not listed
- The Defense Logistics Agency awarded a $3,118.79 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a $3,298.53 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,801.80 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL units, with completion scheduled for September 4, 2025. The contract utilizes firm fixed pricing under a non-competitive, non-set-aside delivery order structure. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $1,179.55 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 19, 2025, with a completion date of August 20, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation, indicating it...
- The Defense Logistics Agency awarded a $6,062.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 mL pens on June 18, 2025, with completion expected by June 20, 2025. This competitive award, made without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a $1,550.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 19, 2025, with completion scheduled for August 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $7,269.12 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on July 22, 2025, with completion targeted for July 23, 2025. This firm fixed-price contract, which was not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a $10,999.90 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price contract is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a delivery order valued at $1,514.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency awarded a $2,962.72 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on May 30, 2025, with completion scheduled for June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJEGCDelivery Order
The Defense Logistics Agency awarded a $37,120.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare systems. The Trulicity delivery under this order supports diabetes management across the Defense Health Agency and other government healthcare customers. As the prime contractor on the SPE2DX global pharmaceutical support vehicle, AmerisourceBergen demonstrates capability to meet federal procurement requirements through open competition, with this order exemplifying the company's ongoing role in fulfilling critical medical supply needs for the Department of Defense and related agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.1k | 9/17/25 |